Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

[Figure: see text].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053646PMC
http://dx.doi.org/10.1161/CIRCRESAHA.120.317076DOI Listing

Publication Analysis

Top Keywords

filamin cardiomyopathy
4
cardiomyopathy variants
4
variants protein
4
protein lysosome
4
lysosome accumulation
4
accumulation [figure
4
[figure text]
4
filamin
1
variants
1
protein
1

Similar Publications

CRISPR activation to repair ECG abnormalities caused by a FLNC truncating variant in mice.

Eur Heart J

August 2025

Myocardial Homeostasis and Cardiac Injury Programme, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Background: Truncating variants in the Filamin C gene (FLNCtv) are a frequent cause of genetic dilated cardiomyopathy (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC), both characterized by arrhythmic complications and increased risk of sudden cardiac death. Currently, no gene-specific therapies exist for FLNCtv-induced cardiomyopathy. CRISPR activation (CRISPRa), which upregulates gene expression via transcriptional activation without cutting the genome, offers a promising strategy, particularly for genes like FLNC whose large size precludes conventional AAV-based gene replacement.

View Article and Find Full Text PDF

Prognostic role of exercise intensity in familial Filamin C truncating variants.

Open Heart

August 2025

Cardiothoracovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste; European Reference Network for Rare, Low-Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart), Trieste, Italy.

Background: Truncating variants in the Filamin C () gene are causative of highly arrhythmogenic cardiomyopathies. Guidelines remain controversial concerning competitive and high-intensity sports for carriers. Indeed, the impact of high-intensity exercise on individuals carrying these variants remains poorly understood.

View Article and Find Full Text PDF

Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study.

JACC Heart Fail

September 2025

Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (member of the European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart), University of Trieste, Italy. Electronic address:

Background: Nexilin (NEXN)-related cardiomyopathies (CMPs) are largely unexplored.

Objectives: This study investigated the causative role of NEXN in CMPs, examining its phenotypic expression and prognostic profile.

Methods: Twelve referral centers collected phenotypic/genotypic data of patients with NEXN variants.

View Article and Find Full Text PDF

We investigated the interaction of HspB7 and its α-crystallin domain with the wild-type (WT) C-terminal fragment of human filamin C (FLNC), containing immunoglobulin-like domains 22-24 and its three mutants associated with cardio- and myopathies. The physicochemical properties of the WT FLNC fragment and its three mutants, p.Glu2472_Asn2473delinsAsp (EN/D) located in the 22nd domain, p.

View Article and Find Full Text PDF